Search result: GB 14232.4-2021
Standard ID | Contents [version] | USD | STEP2 | [PDF] delivered in | Standard Title (Description) | Status | PDF |
GB 14232.4-2021 | English | 549 |
Add to Cart
|
3 days [Need to translate]
|
Plastics collapsible containers for human blood and blood components - Part 4: Aphaeresis blood bag systems with integrated features
| Valid |
GB 14232.4-2021
|
Standard ID | GB 14232.4-2021 (GB14232.4-2021) | Description (Translated English) | Plastics collapsible containers for human blood and blood components -- Part 4: Aphaeresis blood bag systems with integrated features | Sector / Industry | National Standard | Classification of Chinese Standard | C31 | Classification of International Standard | 11.040.20 | Word Count Estimation | 30,340 | Date of Issue | 2021-12-01 | Date of Implementation | 2023-06-01 | Administrative Organization | State Drug Administration | Regulation (derived from) | National Standard Announcement No. 15 of 2021 | Proposing organization | State Drug Administration | Issuing agency(ies) | State Administration for Market Regulation, National Standardization Administration |
GB 14232.4-2021
Plastics collapsible containers for human blood and blood components - Part 4.Aphaeresis blood bag systems with integrated features
ICS 11.040.20
CCSC31
National Standards of People's Republic of China
Bag-type plastic container for human blood and blood components
Part 4.Single blood collection bag system with special components
(ISO 3826-4.2015, MOD)
Released on 2021-12-01
2023-06-01 implementation
State Administration for Market Regulation
Issued by the National Standardization Management Committee
Table of contents
Foreword Ⅲ
Introduction Ⅳ
1 Scope 1
2 Normative references 1
3 Terms and definitions 2
4 size 4
5 Design 9
5.1 Leukocyte-removing filter 9
5.2 Blood sample recognition 9
5.3 Collection needle and return needle 9
5.4 Anti-needle protection device 10
5.5 Sampling device before blood sampling 10
5.6 Red blood cell storage bag 10
5.7 Plasma storage bag 10
5.8 Platelet storage bag 10
5.9 Sampling device after blood collection 10
5.10 Transmission line 10
5.11 Blood transfusion socket 11
5.12 Hanging 11
6 Requirements 11
6.1 General requirements 11
6.2 Physical requirements 11
6.3 Chemical requirements 13
6.4 Biological requirements 14
7 Packaging 14
7.1 General 14
7.2 Shelf life 14
7.3 Outer packaging materials 15
7.4 Tightness of outer packaging 15
7.5 Strength of outer packaging 15
7.6 Placement of components in outer packaging 15
8 Label 15
8.1 General requirements 15
8.2 Labels on plastic blood bags 15
8.3 Outer packaging label 15
8.4 Package insert or instructions for use 16
8.5 Labels on the shipping box 16
8.6 Labeling requirements 16
9 Anticoagulant and/or maintenance fluid 16
Appendix A (Normative) Physical Test 17
Appendix B (Normative) Chemical Test 18
Appendix C (Normative) Biological Test 22
Appendix D (informative) Standard Implementation Guide 24
References 25
Preface
This document is in accordance with the provisions of GB/T 1.1-2020 "Guidelines for Standardization Work Part 1.Structure and Drafting Rules of Standardization Documents"
Drafting.
This document is part 4 of GB 14232 "Bag Plastic Containers for Human Blood and Blood Components". GB 14232 has released the following
part.
---Part 1.Traditional blood bag;
---Part 2.Graphical symbols used for labels and instructions for use;
---Part 3.Blood bag system with special components;
---Part 4.Single blood collection bag system with special components.
This document uses the redrafting law to modify and adopt ISO 3826-4.2015 "Human blood and blood component bag plastic container Part 4
Points. Single blood bag system with special components.
The structure of this document and ISO 3826-4.2015 has been adjusted, and the numbering and sequence of Appendix A and Appendix B have been adjusted.
The technical differences between this document and ISO 3826-4.2015 and the reasons are as follows.
---Regarding normative reference documents, this document has made adjustments with technical differences to adapt to my country's technical conditions and adjustments.
The situation is collectively reflected in Chapter 2 "Normative Reference Documents", and the specific adjustments are as follows.
● Replace ISO 3696 with GB/T 6682, which is modified to adopt international standards;
● Replace ISO 8536-4 with GB 8368, which is modified to adopt international standards;
● Replace ISO 1135-4 with GB 8369.1 which is modified to adopt international standards;
● Replace ISO 10993-1 with GB/T 16886.1 which is equivalent to the international standard;
● Replace ISO 10993-4 with GB/T 16886.4 which is equivalent to adopting international standards;
● Replace ISO 10993-5 with GB/T 16886.5 which is equivalent to adopting international standards;
● Replace ISO 10993-10 with GB/T 16886.10, which is equivalent to the international standard;
● Replace ISO 10993-11 with GB/T 16886.11 which is equivalent to adopting international standards;
● Replace ISO 10993-12 with GB/T 16886.12, which is equivalent to adopting international standards;
● Deleted ISO 3826-1, ISO 3826-2, ISO 3826-3, ISO 15223-1 and ISO 15747;
● Added reference to the "Pharmacopeia of the People's Republic of China".
The following editorial changes have been made to this document.
---Informative Appendix D Standard Implementation Guide has been added.
Please note that some of the contents of this document may involve patents. The issuing agency of this document is not responsible for identifying patents.
This document was proposed and managed by the State Drug Administration.
introduction
If required by the national competent authority, the manufacturer or supplier of plastic blood bags shall submit all plastic materials, material components, and materials to the competent authority.
Details of its production method and detailed production information of plastic blood bags, including the chemical name and content of any additives, and what are these additives
What is added by the manufacturer of the plastic blood bag is the details of the raw materials and all the additives that have been used.
GB 14232 provides the performance requirements and test methods of bag-type plastic containers for human blood and blood components. It consists of four parts.
---Part 1.Traditional blood bag. The purpose is to specify the requirements for airtight, sterile plastic blood bags.
---Part 2.Graphical symbols used for labels and instructions for use. The purpose is to give an expression that can be used for blood collection
Graphical symbols for certain information on medical devices and stored medical devices.
---Part 3.Blood bag system with special components. The purpose is to specify a bag-type non-ventilated aseptic plastic container with special components
(Blood bag system) requirements.
---Part 4.Single blood collection bag system with special components. The purpose is to specify the requirements for a single blood collection bag system with special components.
The purpose of the requirements specified in this document is.
a) Ensure that the blood or blood components maintain the required high quality.
b) As far as possible to ensure the safe and effective collection, inspection, storage, separation and infusion of the inner liquid, especially the risks caused by the following reasons
Minimize.
--- Pollution, especially microbial pollution;
---Air plug;
---Identify errors in representative samples of plastic blood bags and contents;
---The interaction between the plastic blood bag and the liquid inside.
c) When used in conjunction with a blood transfusion set specified in GB 8369.1 or other standards, the function is guaranteed to be applicable.
d) In the case of minimum packaging quality and volume, it can provide adequate protection against damage and deterioration.
Bag-type plastic container for human blood and blood components
Part 4.Single blood bag system with special components
1 Scope
This document specifies the requirements (including performance requirements) for a single blood collection bag system with special components. The single blood bag system includes the
One or more special components given.
These special components refer to.
---Acupuncture protection device;
---Leukocyte-removing filter;
---Sterile barrier filter;
---Sampling device before blood collection;
---Red blood cell storage bag;
---Plasma storage bag;
---Platelet storage bag;
---Polymorphic nuclear (e.g. stem) cell storage bag;
---Sampling device after blood collection;
---Connectors for storage fluid, anticoagulant and substitute fluid.
This document specifies additional requirements for blood bag systems used to collect different amounts of blood components or cells by apheresis separation.
This document applies to automatic or semi-automatic blood collection systems.
2 Normative references
The content of the following documents constitutes an indispensable clause of this document through normative references in the text. Among them, dated quotations
Only the version corresponding to the date is applicable to this document; for undated reference documents, the latest version (including all amendments) is applicable to
This document.
GB/T 6682 Analytical laboratory water specifications and test methods (GB/T 6682-2008, ISO 3696.1987, MOD)
GB 8368 Gravity infusion set for single-use infusion (GB 8368-2018, ISO 8536-4.2010, MOD)
GB 8369.1 Single-use blood transfusion set Part 1.Gravity blood transfusion (GB 8369.1-2019, ISO 1135-4.2015,
MOD)
GB/T 16886.1 Biological Evaluation of Medical Devices Part 1.Evaluation and Testing in the Process of Risk Management (GB/T 16886.1-
2011, ISO 10993-1.2009, IDT)
GB/T 16886.4 Biological Evaluation of Medical Devices Part 4.Test Selection for Interaction with Blood (GB/T 16886.4-2003,
ISO 10993-4.2002, IDT)
GB/T 16886.5 Biological Evaluation of Medical Devices Part 5.In Vitro Cytotoxicity Test (GB/T 16886.5-2017,
ISO 10993-5.2009, IDT)
GB/T 16886.10 Biological Evaluation of Medical Devices Part 10.Irritation and Skin Sensitization Test (GB/T 16886.10-
2017, ISO 10993-10..2010, IDT)
GB/T 16886.11 Biological Evaluation of Medical Devices Part 11.Systemic Toxicity Test (GB/T 16886.11-2011,
ISO 10993-11.2006, IDT)
......
|